# Hematologic cancer trials, no drug phase: 80 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 80 trials with no drug phase for hematologic cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting hematologic cancer trials with no drug phase: 80 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/hematologic-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 80
- Recruiting or not yet: 80
- Read on: November 19, 2026

## Trials

The 25 newest of 80, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07940920 | A Personalised Anti-fatigue Program for Community-dwelling People With Chronic Lymphocytic Leukaemia | University of Surrey | Not applicable | Recruiting | Chronic Lymphocytic Leukemia, Fatigue Syndrome, Chronic | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940920) |
| October 26, 2026 | NCT07895693 | Comprehensive Palliative Care After Stem Cell Transplantation: a Feasability Study | Sponsor not shown (see the record) | Not applicable | Recruiting | Hematopoietic Stem Cell Transplantation (HSCT) | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895693) |
| October 26, 2026 | NCT07894601 | Virtual Reality Intervention to Improve Comfort in Hospitalized Hematology Patients | Fundación para la Investigación del Hospital Clínico de Valencia | Not applicable | Recruiting | Hematologic Cancer | 145 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07894601) |
| October 21, 2026 | NCT07886190 | Symptom Monitoring and Management Intervention After CAR-T | Massachusetts General Hospital | Not applicable | Not yet recruiting | Chimeric Antigen Receptor T-cell Therapy, Hematologic Malignancy | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886190) |
| October 14, 2026 | NCT07872813 | Effects of Resistance Training on Recovery During Hematopoietic Stem Cell Transplantation | Taipei Veterans General Hospital, Taiwan | Not applicable | Not yet recruiting | Hematologic Malignancies, Hematopoietic Stem Cell Transplantation, Resistance Training, Neutropenia, Acute... | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872813) |
| September 29, 2026 | NCT07845669 | Effects of Synbiotic Supplementation on Gastrointestinal Symptoms, Appetite, and Nutritional Recovery in Patients After Autologous Bone... | Alexandria University | Not applicable | Not yet recruiting | Hematologic Neoplasms, Gastrointestinal Symptoms, Malnutrition, Loss of Appetite, Anorexia, Dysbiosis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845669) |
| July 17, 2026 | NCT07710781 | Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic... | Ossium Health, Inc. | Not applicable | Not yet recruiting | Hematologic Malignancy, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710781) |
| July 1, 2026 | NCT07679412 | Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis. | LucasBio | Not applicable | Recruiting | CMV Retinitis | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07679412) |
| June 29, 2026 | NCT07674212 | Take5Care+: A Self-management Educational Intervention | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Hematologic Neoplasms | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07674212) |
| June 2, 2026 | NCT07621887 | Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer | The Hong Kong Polytechnic University | Not applicable | Not yet recruiting | Hematologic Cancer, Leukaemia, Lymphoma, Physical Activity | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621887) |
| May 26, 2026 | NCT07607379 | Robotic Dog Intervention on Emotional Well-Being and Quality of Life | Koç University | Not applicable | Not yet recruiting | Emotional Well-being, Quality of Life, Pediatric Oncology | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07607379) |
| May 11, 2026 | NCT07579065 | HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT | Azienda USL Reggio Emilia - IRCCS | Not applicable | Recruiting | Hematologic Neoplasm, Hematopoietic Stem Cell Transplantation, Survivorship, Cancer Survivorship | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07579065) |
| April 21, 2026 | NCT07541326 | Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France | University Hospital, Limoges | Not applicable | Not yet recruiting | Hematological Malignancies | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07541326) |
| April 9, 2026 | NCT07519811 | LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) | Technical University of Munich | Not applicable | Recruiting | Hematologic Neoplasms, Oncologic Disorders | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07519811) |
| March 6, 2026 | NCT07456189 | The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of... | Institute of Hematology & Blood Diseases Hospital, China | Not applicable | Not yet recruiting | HSCT, Hematologic Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07456189) |
| February 11, 2026 | NCT07403812 | Assessing DCog Short for Neurotoxicity in CAR-T | Beth Israel Deaconess Medical Center | Not applicable | Recruiting | Neurotoxicity, Neurotoxicity Syndromes, Hematologic Malignancy, Immune Effector Cell Associated Neurotoxicity Syndrome | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07403812) |
| December 24, 2025 | NCT07300735 | Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers | Alexandria University | Not applicable | Recruiting | Hematologic Malignancy, Neutropenia, Bone Pain | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07300735) |
| December 18, 2025 | NCT07292272 | Halt Aging in Survivors of Blood Cancers | University of Nebraska | Not applicable | Recruiting | Hematological Malignancy, Leukemia, Lymphoid Leukemia, Multiple Myeloma, Myeloid Leukemia, Monocytic Leukemia... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07292272) |
| December 16, 2025 | NCT07286539 | Precision Physical Exercise for Personalized Onco-Hematology. | University of Salamanca | Not applicable | Not yet recruiting | Hematologic Cancer, Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphocytic Leukemia (CLL), Lung Cancer | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07286539) |
| December 16, 2025 | NCT07285668 | Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With... | University of Wisconsin, Madison | Not applicable | Recruiting | Hematologic Malignancies | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07285668) |
| December 8, 2025 | NCT07270263 | Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies | Medical University of Gdansk | Not applicable | Recruiting | Lymphoma, Leukemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Venous Thromboembolic... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07270263) |
| December 1, 2025 | NCT07255521 | Prehabilitation to Improve Frailty, Function, and Quality of Life in Candidates for Hematopoietic Stem Cell Transplantation | Hospital del Salvador | Not applicable | Not yet recruiting | Hematopoietic Stem Cell Transplantation (HSCT) | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07255521) |
| October 2, 2025 | NCT07203534 | ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period | Wake Forest University Health Sciences | Not applicable | Recruiting | Hematologic Malignancy | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07203534) |
| September 17, 2025 | NCT07179094 | The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Hematologic Neoplasms, Nausea, Vomiting, Anorexia | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07179094) |
| September 15, 2025 | NCT07173166 | Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy | Instituto de Investigacion Sanitaria INCLIVA | Not applicable | Recruiting | Hematologic Cancer | 338 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07173166) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Massachusetts General Hospital | 5 |
| University of Alabama at Birmingham | 2 |
| Alexandria University | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| M.D. Anderson Cancer Center | 2 |
| Centre Hospitalier Universitaire de Nice | 2 |
| Ohio State University Comprehensive Cancer Center | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Dana-Farber Cancer Institute | 2 |
| University Hospital, Limoges | 2 |
| Wake Forest University Health Sciences | 1 |
| Institut Paoli-Calmettes | 1 |
| Nationwide Children's Hospital | 1 |
| Children's Hospital of Fudan University | 1 |
| National Cancer Institute, Slovakia | 1 |
| Thomas Jefferson University | 1 |
| [Miltenyi Biomedicine GmbH](https://specstream.ai/data/clinical-trials/company/miltenyi-biomedicine-gmbh) | 1 |
| Zhongnan Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Institut Bergonié | 1 |
| Fundación para la Investigación del Hospital Clínico de Valencia | 1 |
| Washington University School of Medicine | 1 |
| Koç University | 1 |
| University of Florida | 1 |
| Taipei Veterans General Hospital, Taiwan | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 36 |
| France | 10 |
| China | 3 |
| Egypt | 2 |
| Spain | 2 |
| Germany | 2 |
| Italy | 2 |
| Slovakia | 1 |
| Taiwan | 1 |
| Poland | 1 |
| United Kingdom | 1 |
| Ireland | 1 |
| Chile | 1 |
| Tunisia | 1 |
| Denmark | 1 |
| Hong Kong | 1 |
| South Korea | 1 |
| Switzerland | 1 |
| Canada | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Contractors in the United States](https://specstream.ai/data/businesses/contractors/united-states)
- [Neurology practices in the United States](https://specstream.ai/data/businesses/neurology-practices/united-states)
- [Appellate practice law firms in the United States](https://specstream.ai/data/businesses/appellate-practice-law-firms/united-states)
- [Glass manufacturers in the United States](https://specstream.ai/data/businesses/glass-manufacturers/united-states)
- [Shared office spaces in the United States](https://specstream.ai/data/businesses/shared-office-spaces/united-states)
- [Cocktail bars in the United States](https://specstream.ai/data/businesses/cocktail-bars/united-states)
